BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang M, Jin L, Duan YL, Yang J, Huang S, Jin M, Zhu GH, Gao C, Liu Y, Zhang N, Zhou CJ, Gao ZF, Zheng QL, Chen D, Zhang YH. Diagnosis and treatment of pediatric anaplastic lymphoma kinase-positive large B-cell lymphoma: A case report. World J Clin Cases 2021; 9(17): 4268-4278 [PMID: 34141790 DOI: 10.12998/wjcc.v9.i17.4268]
URL: https://www.wjgnet.com/2307-8960/full/v9/i17/4268.htm
Number Citing Articles
1
Hitoshi Ohno, Kayo Takeoka, Chiyuki Kishimori, Fumiyo Maekawa, Miho Nakagawa, Katsuhiro Fukutsuka, Masahiko Hayashida, Gen Honjo. ALK-positive large B-cell lymphoma showing long-term response to conventional chemoradiotherapyTenri Medical Bulletin 2021; 24(2): 100 doi: 10.12936/tenrikiyo.24-017
2
Sunil Sam Varghese, Ashish Varghese, Preethi Anni Mercy Paul, Kaffy Dhawan, Pulkit Gupta. Laryngeal Anaplastic Lymphoma Kinase-Positive B-cell Lymphoma: Case Report and ReviewIndian Journal of Otolaryngology and Head & Neck Surgery 2023; 75(3): 2328 doi: 10.1007/s12070-023-03640-5
3
Radhika Takiar, Tycel J. Phillips. Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphomaBlood Advances 2023; 7(12): 2912 doi: 10.1182/bloodadvances.2022007537